GILEAD SCIENCES, INC. (GILD) /
The cash flow of GILEAD SCIENCES, INC. over the past 10 years
Chart GILEAD SCIENCES, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, GILEAD SCIENCES, INC.'s operating cash flow was $10.02B and its capital expenditures $563M, leaving free cash flow of $9.46B. Free cash flow was above zero in all 10 years shown. It ranged from $7.42B in fiscal 2023 to $16.3B in fiscal 2016. Capital expenditures were highest in fiscal 2018, at $924M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $10.02B | $563M | $9.46B |
| 2024ended Dec 31, 2024 | $10.83B | $523M | $10.3B |
| 2023ended Dec 31, 2023 | $8.01B | $585M | $7.42B |
| 2022ended Dec 31, 2022 | $9.07B | $728M | $8.34B |
| 2021ended Dec 31, 2021 | $11.38B | $579M | $10.8B |
| 2020ended Dec 31, 2020 | $8.17B | $650M | $7.52B |
| 2019ended Dec 31, 2019 | $9.14B | $825M | $8.32B |
| 2018ended Dec 31, 2018 | $8.4B | $924M | $7.48B |
| 2017ended Dec 31, 2017 | $11.9B | $590M | $11.31B |
| 2016ended Dec 31, 2016 | $17.05B | $748M | $16.3B |
Fiscal years as GILEAD SCIENCES, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on GILEAD SCIENCES, INC.
- The revenue of GILEAD SCIENCES, INC.
- The profitability of GILEAD SCIENCES, INC.
- The debt of GILEAD SCIENCES, INC.
- The dividends of GILEAD SCIENCES, INC.
- All of GILEAD SCIENCES, INC.'s financials, charted
Companies of a similar size
- DISWALT DISNEY CO/
- KLACKLA Corporation
- CRMSalesforce, Inc.
- SNDKSandisk Corporation
- MRVLMARVELL TECHNOLOGY, INC
Not investment advice. This page shows what GILEAD SCIENCES, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.